{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:17:08Z","timestamp":1768526228659,"version":"3.49.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The alarmin cytokine interleukin (IL)-33 plays an important proinflammatory role in type 2 immunity and can act on type 2 innate lymphoid cells (ILC2s) and type 2 T helper (T<jats:sub>H<\/jats:sub>2) cells in eosinophilic inflammation and asthma. The mechanistic target of rapamycin (mTOR) signaling pathway drives immune responses in several inflammatory diseases, but its role in regulating bone marrow responses to IL-33 is unclear. The aim of this study was to determine the role of the mTORC1 signaling pathway in IL-33-induced bone marrow ILC2 responses and its impact on IL-33-induced eosinophilia. Wild-type mice were intranasally exposed to IL-33 only or in combination with the mTORC1 inhibitor, rapamycin, intraperitoneally. Four groups were included in the study: saline-treated (PBS)+PBS, rapamycin+PBS, PBS+IL-33 and rapamycin+IL-33. Bronchoalveolar lavage fluid (BALF), serum and bone marrow cells were collected and analyzed by differential cell count, enzyme-linked immunosorbent assay and flow cytometry. IL-33 induced phosphorylation of the mTORC1 protein rpS6 in bone marrow ILC2s both <jats:italic>ex vivo<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. The observed mTOR signal was reduced by rapamycin treatment, indicating the sensitivity of bone marrow ILC2s to mTORC1 inhibition. IL-5 production by ILC2s was reduced in cultures treated with rapamycin before stimulation with IL-33 compared to IL-33 only. Bone marrow and airway eosinophils were reduced in mice given rapamycin before IL-33-exposure compared to mice given IL-33 only. Bone marrow ILC2s responded to IL-33 <jats:italic>in vivo<\/jats:italic> with increased mTORC1 activity and rapamycin treatment successfully decreased IL-33-induced eosinophilic inflammation, possibly by inhibition of IL-5-producing bone marrow ILC2s. These findings highlight the importance of investigating specific cells and proinflammatory pathways as potential drivers of inflammatory diseases, including asthma.<\/jats:p>","DOI":"10.3389\/fimmu.2022.915906","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T06:26:25Z","timestamp":1654237585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Rapamycin Dampens Inflammatory Properties of Bone Marrow ILC2s in IL-33-Induced Eosinophilic Airway Inflammation"],"prefix":"10.3389","volume":"13","author":[{"given":"Emma","family":"Boberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Malmh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Calv\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Corciulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"R\u00e5dinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-110119-091711","article-title":"Group 2 Innate Lymphoid Cells: Team Players in Regulating Asthma","volume":"39","author":"Rodriguez-Rodriguez","year":"2021","journal-title":"Annu Rev Immun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2014.11.037","article-title":"Persistence of Asthma Requires Multiple Feedback Circuits Involving Type 2 Innate Lymphoid Cells and Il-33","volume":"136","author":"Christianson","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200805-666OC","article-title":"Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent Upon Disruption of the T1\/St2-Il-33 Pathway","volume":"179","author":"Kearley","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302984","article-title":"Il-33 and Thymic Stromal Lymphopoietin Mediate Immune Pathology in Response to Chronic Airborne Allergen Exposure","volume":"193","author":"Iijima","year":"2014","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000488015","article-title":"Il-33 and Its Receptor St2 After Inhaled Allergen Challenge in Allergic Asthmatics","volume":"176","author":"Mitchell","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003059107","article-title":"Il-33 Is a Crucial Amplifier of Innate Rather Than Acquired Immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600611","article-title":"Il-33 Precedes Il-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis","volume":"197","author":"Johnston","year":"2016","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"Il-33 Induces Antigen-Specific Il-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of Il-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01058","article-title":"Interplay Between the Il-33\/St2 Axis and Bone Marrow Ilc2s in Protease Allergen-Induced Il-5-Dependent Eosinophilia","volume":"11","author":"Boberg","year":"2020","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1038\/s41598-017-03674-0","article-title":"Interleukin 33 Exacerbates Antigen Driven Airway Hyperresponsiveness, Inflammation and Remodeling in a Mouse Model of Asthma","volume":"7","author":"Sj\u00f6berg","year":"2017","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12931-021-01799-5","article-title":"Neutralization of Il-33 Modifies the Type 2 and Type 3 Inflammatory Signature of Viral Induced Asthma Exacerbation","volume":"22","author":"Warren","year":"2021","journal-title":"Respir Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased Expression of Il-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells","volume":"183","author":"Pr\u00e9fontaine","year":"2009","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/ijpvm.IJPVM_179_16","article-title":"Comparison of Interleukin-33 Serum Levels in Asthmatic Patients With a Control Group and Relation With the Severity of the Disease","volume":"8","author":"Momen","year":"2017","journal-title":"Int J Prev Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12724","article-title":"Elevated Levels of Interleukin-33 Are Associated With Allergic and Eosinophilic Asthma","volume":"89","author":"Gasiuniene","year":"2019","journal-title":"Scand J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.24.021605.090720","article-title":"The Eosinophil","volume":"24","author":"Rothenberg","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1165\/ajrcmb.20.1.3449","article-title":"Cd34(+)\/Interleukin-5ralpha Messenger Rna+ Cells in the Bronchial Mucosa in Asthma: Potential Airway Eosinophil Progenitors","volume":"20","author":"Robinson","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3489","article-title":"Innate Lymphoid Cells as Regulators of Immunity, Inflammation and Tissue Homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130351","article-title":"A Role for Il-25 and Il-33-Driven Type-2 Innate Lymphoid Cells in Atopic Dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201406-1039OC","article-title":"Il-33-Dependent Type 2 Inflammation During Rhinovirus-Induced Asthma Exacerbations in Vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12842","article-title":"Bone Marrow Type 2 Innate Lymphoid Cells: A Local Source of Interleukin-5 in Interleukin-33-Driven Eosinophilia","volume":"153","author":"Johansson","year":"2018","journal-title":"Immunology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113751","article-title":"House Dust Mite Induces Bone Marrow Il-33-Responsive Ilc2s and T(H) Cells","volume":"21","author":"Boberg","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of Innate Immune Cell Function by Mtor","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017","article-title":"Mtor Signaling in Growth Control and Disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12727","article-title":"The Clinical and Mechanistic Intersection of Primary Atopic Disorders and Inborn Errors of Growth and Metabolism","volume":"287","author":"Lyons","year":"2019","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3898","article-title":"Germline Hypomorphic Card11 Mutations in Severe Atopic Disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab834","article-title":"Mtor Activation in Cd8+ Cells Contributes to Disease Activity of Rheumatoid Arthritis and Increases Therapeutic Response to Tnf Inhibitors","author":"Zhang","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108563","article-title":"Zinc Salicylate Reduces Airway Smooth Muscle Cells Remodelling by Blocking Mtor and Activating P21((Waf1\/Cip1))","volume":"89","author":"Fang","year":"2021","journal-title":"J Nutr Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033984","article-title":"Paradoxical Effects of Rapamycin on Experimental House Dust Mite-Induced Asthma","volume":"7","author":"Fredriksson","year":"2012","journal-title":"PLos One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12554","article-title":"Rapamycin Inhibition of Eosinophil Differentiation Attenuates Allergic Airway Inflammation in Mice","volume":"20","author":"Hua","year":"2015","journal-title":"Respirology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.018","article-title":"Il-33 Induces Innate Lymphoid Cell-Mediated Airway Inflammation by Activating Mammalian Target of Rapamycin","volume":"130","author":"Salmond","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1038\/s41598-017-04826-y","article-title":"Activation of the Mtor Signaling Pathway Is Required for Asthma Onset","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.08.009","article-title":"Tissue-Specific Features of Innate Lymphoid Cells","volume":"41","author":"Meininger","year":"2020","journal-title":"Trends Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0201-4","article-title":"Tissue Signals Imprint Ilc2 Identity With Anticipatory Function","volume":"19","author":"Ricardo-Gonzalez","year":"2018","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00051","article-title":"Understanding Interleukin 33 and Its Roles in Eosinophil Development","volume":"4","author":"Johnston","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425043","article-title":"Allergen-Induced Traffic of Bone Marrow Eosinophils, Neutrophils and Lymphocytes to Airways","volume":"34","author":"Johansson","year":"2004","journal-title":"Eur J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.03.048","article-title":"Eosinophil Trafficking in Allergy and Asthma","volume":"119","author":"Rosenberg","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1038\/s41598-018-25358-z","article-title":"Mtor Complexes Differentially Orchestrates Eosinophil Development in Allergy","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.09.004","article-title":"Il-33: An Alarmin Cytokine With Crucial Roles in Innate Immunity, Inflammation and Allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in Health and Disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00260-2020","article-title":"Anti-Alarmins in Asthma: Targeting the Airway Epithelium With Next-Generation Biologics","volume":"56","author":"Porsbjerg","year":"2020","journal-title":"Eur Respir J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and Safety of Itepekimab in Patients With Moderate-To-Severe Asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.915906\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T06:26:27Z","timestamp":1654237587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.915906\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2022.915906"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.915906","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"article-number":"915906"}}